Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Natural products can help overcome cancer drug resistance.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

H19 boosts hair growth potential by activating Wnt signaling, possibly helping treat hair loss.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Phytosomes improve the body's absorption of plant extracts for better health benefits.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.